Two recent articles this past week highlight issues that question the validity of FDA approval of new drugs. This is on the heels of the spotlight on Big Pharma’s efforts to circumvent the Hatch-Waxman provisions designed to encourage generic company challenges to weak drug patents, and alleged abuse of the citizen petition process. In sum, […]
On Thursday, Pfizer announced that it plans to introduce a generic version of its antidepressant Zoloft in the United States as soon as a rival generic hits the market, which could be as early as Saturday (in what is known as the sale of an “authorized generic”). The patent on Zoloft expires in two days. […]
Patent Baristas: Can Patent Legal Work be a Commodity? (tags: USPTO patents law) Patent Baristas: USPTO Denies Patent for a Hybrid as Being Too-Human (tags: USPTO patents) Frost Brown Todd (tags: lawyers patent+attorneys) AIPLA | Home (tags: patent+law+association)
Maybe it’s the cold weather and the gloom of February, but cupid did not bestow any Valentine’s day gifts on the biotech industry for the month of February. “Although the biotech industry managed to hold its own during much of the month with the Burrill Select Index up slightly into the final weekend of February, […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
